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condition and graft dysfunction in this
critically ill population (9,10).
Prospective studies identifying and
quantifying endotoxin in the trans-
planted liver itself and in the recipient
may be valuable in assessing the
meaning of this finding. An assess-
ment of endotoxin transfer will assist
in further defining the risks associated
with organ transplantation from
donors with N. meningitidis infections
and may lead to the consideration of
additional interventions to mediate
the effects of endotoxin exposure. 
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Surveillance of
Human Calicivirus
in Spain 
To the Editor: Human calicivirus-
es (HuCVs) are an important cause of
acute viral gastroenteritis in young
children worldwide (1,2). In Spain,
norovirus infections are not subject to
specific surveillance; few data exist
about sporadic cases (3,4) and none
about outbreaks across the country.
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Figure. Pre-and posttransplantation serum antibodies as measured by enzyme-linked immunosorbent assay (ELISA). A) Immunoglobulin
(Ig) G antibodies to Neisseria meningitidis serogroup C capsular polysaccharide (CPS) determined as described by Arakere and Frasch
(7) with minor modifications. Samples were run in duplicate at 8 serial dilutions, and antibody concentrations were calculated relative to
the standard reference serum lot CDC 1992 (courtesy of G. Carlone, Centers for Disease Control and Prevention, Atlanta, GA). B) IgM
antibodies to N. meningitidis lipooligosaccharide (LOS) immunotypes (L2, L3, L7, L9). ELISA to detect antibodies to LOS immunotypes
L2, L3, L7, or L9 was performed as described (8), with minor modifications, by using goat antihuman IgG (g-specific, Kirkegaard & Perry,
Gaithersburg, MD, USA) or goat antihuman IgM (m-specific, Sigma, St. Louis, MO, USA) conjugated to alkaline phosphatase. Samples
were run in duplicate at 4 serial dilutions. OD, optical density.LETTERS
We have conducted a surveillance
study of acute gastroenteritis epi-
demics to determine the prevalence of
HuCV infections. Our goal was to
gain insight into the epidemiology of
these infections in Spain and consider
new directions to prevent them and
control improvements in food and
water quality and sanitary practices.
From October 1998 to October
1999, a pilot prospective program
was designed to study viral strains
causing annual epidemics of severe
diarrhea in children. A total of 822
stool specimens were obtained from
children  <4 years of age with
sporadic gastroenteritis, who visited
the emergency room of a hospital in
Madrid. Agastroenteritis episode was
defined as <3 looser-than-normal
stools within a 24-h period. Clinical
and epidemiologic information was
collected. No pathogens were detect-
ed in fecal specimens from 292 chil-
dren. A subset of 201 of these sam-
ples was tested for HuCVs.
Additionally, 741 fecal samples
were collected from 135 outbreaks
that occurred throughout Spain (13 of
17 geographic areas) from 2000 to
2002. An outbreak was defined with
Kaplan criteria (5). Epidemiologic
data (mode of transmission, setting
and size of the outbreak, persons
affected, persons at risk, attack rate,
and age of affected persons) were
recorded on a standardized form sub-
mitted to the National Microbiology
Center.
Enteropathogenic bacteria in fecal
specimens were examined by conven-
tional culture procedures. Viruses
(group A rotavirus, adenovirus, and
astrovirus) were also examined by
commercial enzyme immunoassay
(Dako Diagnostics, Cambridgeshire,
UK). In negative samples (1,033 of
1,563), viral RNA was extracted as
described (3) and analyzed by reverse
transcription–polymerase chain reac-
tion (RT-PCR) for HuCVs by using
JV12/JV13 primers (6). RT-
PCR–negative samples were also
reanalyzed with p289/290 (7) and
NVp110-Nvp69 (8) primers pair,
which detect sapovirus. HuCV-posi-
tive specimens were confirmed and
genetically characterized by the
reverse line blot hybridization method
(9) and sequencing assays by using
High Pure PCR Product Purification
kit (Boehringer, Mannheim, Germany)
and ABI PRISM BigDye Terminator
Cycle Sequencing Reaction Kit
(Perkin Elmer Biosystems, Foster
City, CA, USA) on an automated
sequencer (Applied Biosystems model
3700). For HuCV phylogenetic analy-
ses, a multiple-sequence alignment
was generated from the consensus
sequence of each of the isolates and
the reference strains by using
ClustalX 1.8 methods. The nucleotide
sequences were analyzed with the
MEGA 2.1 analytical package by
using neighbor-joining methods and
Kimura 2-parameters algorithm.
GenBank accession numbers for
sequences described in this study are
AY207341–AY207365.
In pediatric gastroenteritis cases,
HuCVs were detected by RT-PCR in
63 specimens (31%). Twenty-nine of
these were genotyped, and results of
phylogenetic analyses are shown in
the Table. The median age of children
with HuCV infection was 15 months
(range 1–47). In HuCV-positive cases,
83% were associated with vomiting,
32% with fever, 24% with mild dehy-
dration, and 2% with severe dehydra-
tion. Hospitalization was required in
13% of the cases.
Additionally, noroviruses were
detected in 85 (63%) of 135 out-
breaks. Seventy- seven (91%) of them
were segregated into genogroup II
(Table). Detection rates within out-
breaks ranged from 13% to 100%.
The setting was provided for 82
(97%) of 85 norovirus outbreaks.
Nursing homes (57%) were the most
common setting, followed by schools
(10%), camping and vacation destina-
tions (7%), hospitals (6%), and
restaurants and hotels (4% each). The
attack rate was provided for 33 (39%)
norovirus outbreaks, and the median
number of persons affected was 35.
The mode of transmission was pro-
vided for 30 (35%) of the norovirus-
positive outbreaks; the most common
mode of transmission was person-to-
person contact (n = 15), followed by
contaminated food (n = 10) and con-
taminated water (n = 5).
This report shows the importance
and diversity of HuCVs circulating
throughout Spain. Noroviruses partic-
ularly have been found as a main
causative agent of sporadic pediatric
cases and outbreaks. The lower preva-
lence of sapovirus is similar to that
shown by other authors (2), perhaps
because sapovirus causes milder
symptoms than norovirus. Analysis
showed the predominance of
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norovirus genogroup II and Lordsdale
cluster as the main genotypes both in
sporadic cases and outbreaks, also
shown in other reports (1,2,6).
Our study confirms that norovirus-
es are the main cause of nonbacterial
gastroenteritis outbreaks throughout
Spain, as in other European countries
(1,10). However, we consider that
HuCV infections could be underdiag-
nosed because a substantial number of
nonbacterial outbreaks are labeled of
unknown etiology. The systematic
application of sensitive techniques to
detect these viruses, as well as a more
systematic surveillance system for
viral diarrhea, would provide broader
knowledge of norovirus infection in
Spain.
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Correction, vol. 11, no. 6
In “Community-acquired Methicillin-resistant Staphylococcus aureus,
Uruguay” by Xiao Xue Ma et al., errors occurred on pages 973 and 974. 
The first sentence of the abstract should read as follows: A novel,
methicillin-resistant Staphylococcus aureus clone (Uruguay clone) with a
non–multidrug-resistant phenotype caused a large outbreak, including 7
deaths, in Montevideo, Uruguay.
The first sentence of the article should read as follows: Since the 1990s,
methicillin-resistant Staphylococcus aureus (MRSA) infections have been
increasingly recognized in the community, and MRSA strains isolated
from patients with community-associated cases have been called commu-
nity-associated MRSA (CA-MRSA).
The first sentence of Figure 1 legend (p. 974) should read as follows:
The monthly accumulation of cases of infections due to non–multidrug-
resistant MRSA strains from January 2002 to October 2003.
The corrected article appears online at http://www.cdc.gov/ncidod/eid/
vol11no06/04-1059.htm
We regret any confusion these errors may have caused.
Search